title: Tourette syndrome.
abstract: Tourette syndrome (TS) is a neuro-developmental disorder of childhood that is often associated with various psychiatric morbidities. Timely diagnosis and appropriate management can significantly impact psychosocial functioning. Morbidities may be a major source of disability, and may determine ultimate prognosis, although most children will experience significant improvement or resolution of symptoms by adulthood. Additional management considerations must be made in those with TS symptoms persisting into adulthood. The mainstay of therapy remains dopamine receptor blocking drugs, but new therapies are emerging.
authors: Department of Neurology, Plummer Movement Disorders Center, Scott & White Healthcare, Temple, TX 76508, USA. jjimenezshahed@swmail.sw.org
authors: Joohi
authors: J
authors: Jimenez-Shahed
mesh_terms: D017668:Age of Onset; D000375:Aging; D001921:Brain / Q000503:physiopathology; D002648:Child; D015897:Comorbidity; D003937:Diagnosis, Differential; D018492:Dopamine Antagonists / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D015995:Prevalence; D011379:Prognosis; D013981:Tic Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D005879:Tourette Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*
chemical_list: D018492:Dopamine Antagonists